{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:16:52Z","timestamp":1788898612626,"version":"build-2803163510"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06015-3","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:38:19Z","timestamp":1781872699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer\u2019s Disease Axis"],"prefix":"10.1007","volume":"63","author":[{"given":"S. N.","family":"Amruthavarshini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitu","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"2","key":"6015_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q (2022) Alzheimer\u2019s disease: epidemiology and clinical progression. Neurol Ther 11(2):553\u2013569. https:\/\/doi.org\/10.1007\/s40120-022-00338-8","journal-title":"Neurol Ther"},{"issue":"6","key":"6015_CR2","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.4103\/1673-5374.386406","volume":"19","author":"M Abyadeh","year":"2024","unstructured":"Abyadeh M et al (2024) Amyloid-beta and tau protein beyond Alzheimer\u2019s disease. Neural Regen Res 19(6):1262\u20131276. https:\/\/doi.org\/10.4103\/1673-5374.386406","journal-title":"Neural Regen Res"},{"issue":"22","key":"6015_CR3","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.3390\/ijms232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri E et al (2022) Alzheimer\u2019s disease treatment strategies and limitations. Int J Mol Sci 23(22):13954. https:\/\/doi.org\/10.3390\/ijms232213954","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6015_CR4","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1093\/brain\/awac208","volume":"145","author":"S Ramanan","year":"2022","unstructured":"Ramanan S, Irish M, Patterson K, Rowe JB, Gorno-Tempini ML, Lambon Ralph MA (2022) Multidimensional cognitive deficits in logopenic variant primary progressive aphasia. Brain 145(9):2955\u20132966. https:\/\/doi.org\/10.1093\/brain\/awac208","journal-title":"Brain"},{"issue":"12","key":"6015_CR5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/life14121555","volume":"14","author":"R Cacabelos","year":"2024","unstructured":"Cacabelos R, Mart\u00ednez-Iglesias O, Cacabelos N, Carrera I, Corzo L, Naidoo V (2024) Therapeutic options in Alzheimer\u2019s disease: from classic acetylcholinesterase inhibitors to multi-target drugs with pleiotropic activity. Life 14(12):1555. https:\/\/doi.org\/10.3390\/life14121555","journal-title":"Life"},{"key":"6015_CR6","doi-asserted-by":"publisher","first-page":"1604378","DOI":"10.3389\/fnagi.2025.1604378","volume":"17","author":"K Zhang","year":"2025","unstructured":"Zhang K et al (2025) NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies. Front Aging Neurosci 17:1604378. https:\/\/doi.org\/10.3389\/fnagi.2025.1604378","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"6015_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/jpm15090437","volume":"15","author":"AE Alkhalifa","year":"2025","unstructured":"Alkhalifa AE, Al Mokhlf A, Ali H, Al-Ghraiybah NF, Syropoulou V (2025) Anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease. J Pers Med 15(9):437. https:\/\/doi.org\/10.3390\/jpm15090437","journal-title":"J Pers Med"},{"issue":"4","key":"6015_CR8","doi-asserted-by":"publisher","first-page":"9605","DOI":"10.1097\/JS9.0000000000004619","volume":"112","author":"G Yu","year":"2026","unstructured":"Yu G et al (2026) 3,4-Dimethoxychalcone-induced caloric restriction inhibits PANoptosis to promote ischemic and diabetic skin flap survival: experimental studies. Int J Surg 112(4):9605\u20139613. https:\/\/doi.org\/10.1097\/JS9.0000000000004619","journal-title":"Int J Surg"},{"issue":"8","key":"6015_CR9","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1002\/alz.14057","volume":"20","author":"Y Liang","year":"2024","unstructured":"Liang Y et al (2024) The link between gut microbiome and Alzheimer\u2019s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer\u2019s disease. Alzheimers Dement 20(8):5771\u20135788. https:\/\/doi.org\/10.1002\/alz.14057","journal-title":"Alzheimers Dement"},{"key":"6015_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s44400-025-00048-6","volume":"1","author":"S Kumari","year":"2025","unstructured":"Kumari S, Desai V, Sivakumar S (2025) Association between gut microbial dysbiosis and Alzheimer\u2019s disease: an umbrella review. NPJ Dement 1:41. https:\/\/doi.org\/10.1038\/s44400-025-00048-6","journal-title":"NPJ Dement"},{"key":"6015_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.106138","volume":"131","author":"M Marizzoni","year":"2025","unstructured":"Marizzoni M et al (2025) Microbiota\u2013gut\u2013brain axis dysregulation and probiotic modulation in Alzheimer\u2019s disease. Brain Behav Immun 131:106138. https:\/\/doi.org\/10.1016\/j.bbi.2025.106138","journal-title":"Brain Behav Immun"},{"key":"6015_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13041-025-01263-1","volume":"18","author":"Y Vaziri","year":"2025","unstructured":"Vaziri Y, Olia JBH, Avci CB (2025) Molecular mechanisms of gut microbiota dysbiosis and metabolites in Alzheimer\u2019s disease. Mol Brain 18:63. https:\/\/doi.org\/10.1186\/s13041-025-01263-1","journal-title":"Mol Brain"},{"key":"6015_CR13","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.3390\/jcm11144119","volume":"11","author":"M Biazzo","year":"2022","unstructured":"Biazzo M, Deidda G (2022) Fecal microbiota transplantation as new therapeutic avenue for human diseases. J Clin Med 11:4119. https:\/\/doi.org\/10.3390\/jcm11144119","journal-title":"J Clin Med"},{"key":"6015_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12868-025-00953-9","volume":"26","author":"P Upadhyay","year":"2025","unstructured":"Upadhyay P, Kumar S, Tyagi A (2025) Gut microbiome rewiring via fecal transplants in Alzheimer\u2019s disease models. BMC Neurosci 26:39. https:\/\/doi.org\/10.1186\/s12868-025-00953-9","journal-title":"BMC Neurosci"},{"key":"6015_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13195-024-01587-5","volume":"16","author":"X Gu","year":"2024","unstructured":"Gu X, Fan M, Zhou Y (2024) Intestinal endogenous metabolites regulate neuroinflammation in 5\u00d7FAD mice via the gut\u2013brain axis. Alzheimers Res Ther 16:222. https:\/\/doi.org\/10.1186\/s13195-024-01587-5","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"6015_CR16","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1007\/s12035-024-04513-w","volume":"62","author":"L Junyi","year":"2025","unstructured":"Junyi L et al (2025) Gut microbiota mediates neuroinflammation in Alzheimer\u2019s disease: unraveling key factors and mechanistic insights. Mol Neurobiol 62(3):3746\u20133763. https:\/\/doi.org\/10.1007\/s12035-024-04513-w","journal-title":"Mol Neurobiol"},{"issue":"5","key":"6015_CR17","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1007\/s12035-024-04685-5","volume":"62","author":"S Kaur","year":"2025","unstructured":"Kaur S, Kumari D, Dandekar MP (2025) Importance of gut microbiota dysbiosis and circadian disruption-associated biomarkers in the emergence of Alzheimer\u2019s disease. Mol Neurobiol 62(5):6308\u20136316. https:\/\/doi.org\/10.1007\/s12035-024-04685-5","journal-title":"Mol Neurobiol"},{"issue":"1","key":"6015_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12035-024-04290-6","volume":"62","author":"L Xiang","year":"2025","unstructured":"Xiang L et al (2025) Underlying mechanism of lysosomal membrane permeabilization in CNS injury: a literature review. Mol Neurobiol 62(1):626\u2013642. https:\/\/doi.org\/10.1007\/s12035-024-04290-6","journal-title":"Mol Neurobiol"},{"issue":"8","key":"6015_CR19","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s12276-024-01282-3","volume":"56","author":"YH Jung","year":"2024","unstructured":"Jung YH, Chae CW, Han HJ (2024) The potential role of gut microbiota-derived metabolites as regulators of metabolic syndrome-associated mitochondrial and endolysosomal dysfunction in Alzheimer\u2019s disease. Exp Mol Med 56(8):1691\u20131702. https:\/\/doi.org\/10.1038\/s12276-024-01282-3","journal-title":"Exp Mol Med"},{"issue":"1","key":"6015_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13195-025-01683-0","volume":"17","author":"H Zhao","year":"2025","unstructured":"Zhao H et al (2025) Multi-omics identification of gut microbiota\u2013metabolite\u2013brain\u2013cognition pathways. Alzheimers Res Ther 17(1):36. https:\/\/doi.org\/10.1186\/s13195-025-01683-0","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"6015_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/cimb47070489","volume":"47","author":"I Savulescu-Fiedler","year":"2025","unstructured":"Savulescu-Fiedler I, Benea SN, C\u0103runtu C, Nancoff AS, Homentcovschi C, Bucurica S (2025) Rewiring the brain through the gut. Curr Issues Mol Biol 47(7):489. https:\/\/doi.org\/10.3390\/cimb47070489","journal-title":"Curr Issues Mol Biol"},{"key":"6015_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-025-04776-7","volume":"398","author":"M Aijaz","year":"2025","unstructured":"Aijaz M, Ahmad M, Ahmad S, Afzal M, Kothiyal P (2025) Gut\u2013brain axis in neurological disease pharmacotherapeutics. Naunyn Schmiedebergs Arch Pharmacol 398:1\u201314. https:\/\/doi.org\/10.1007\/s00210-025-04776-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"6015_CR23","doi-asserted-by":"publisher","first-page":"1600148","DOI":"10.3389\/fnins.2025.1600148","volume":"19","author":"JM Pfaffinger","year":"2025","unstructured":"Pfaffinger JM, Hays KE, Seeley J, Ramesh Babu P, Ryznar R (2025) Gut dysbiosis as a driver of Parkinson\u2019s and Alzheimer\u2019s disease. Front Neurosci 19:1600148. https:\/\/doi.org\/10.3389\/fnins.2025.1600148","journal-title":"Front Neurosci"},{"key":"6015_CR24","doi-asserted-by":"publisher","first-page":"1584023","DOI":"10.3389\/fimmu.2025.1584023","volume":"16","author":"X Xie","year":"2025","unstructured":"Xie X, Chen X, Wang X, Wang S, Qi P (2025) Dual regulatory effects of gut microbiota in rheumatoid arthritis. Front Immunol 16:1584023. https:\/\/doi.org\/10.3389\/fimmu.2025.1584023","journal-title":"Front Immunol"},{"key":"6015_CR25","doi-asserted-by":"publisher","first-page":"1718358","DOI":"10.3389\/fmicb.2025.1718358","volume":"16","author":"Q Jin","year":"2025","unstructured":"Jin Q, Li X, Liu Z, Qi T, Xiao D, Yang W (2025) Gut microbiota and host DNA methylation in IBD. Front Microbiol 16:1718358. https:\/\/doi.org\/10.3389\/fmicb.2025.1718358","journal-title":"Front Microbiol"},{"issue":"1","key":"6015_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/nu13010037","volume":"13","author":"A Megur","year":"2021","unstructured":"Megur A, Baltriukien\u0117 D, Bukelskien\u0117 V, Burokas A (2021) The microbiota\u2013gut\u2013brain axis and Alzheimer\u2019s disease: neuroinflammation is to blame? Nutrients 13(1):37. https:\/\/doi.org\/10.3390\/nu13010037","journal-title":"Nutrients"},{"key":"6015_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2024.101776","volume":"39","author":"R Pourahmad","year":"2024","unstructured":"Pourahmad R et al (2024) Exploring the effect of gut microbiome on Alzheimer\u2019s disease. Biochem Biophys Rep 39:101776. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101776","journal-title":"Biochem Biophys Rep"},{"issue":"12","key":"6015_CR28","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/brainsci14121224","volume":"14","author":"AA Menezes","year":"2024","unstructured":"Menezes AA, Shah ZA (2024) A review of the consequences of gut microbiota in neurodegenerative disorders and aging. Brain Sci 14(12):1224. https:\/\/doi.org\/10.3390\/brainsci14121224","journal-title":"Brain Sci"},{"issue":"11","key":"6015_CR29","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/jcm10112358","volume":"10","author":"MG Giovannini","year":"2021","unstructured":"Giovannini MG, Lana D, Traini C, Vannucchi MG (2021) The microbiota\u2013gut\u2013brain axis and Alzheimer disease: from dysbiosis to neurodegeneration\u2014focus on central nervous system glial cells. J Clin Med 10(11):2358. https:\/\/doi.org\/10.3390\/jcm10112358","journal-title":"J Clin Med"},{"key":"6015_CR30","doi-asserted-by":"publisher","first-page":"1422350","DOI":"10.3389\/fnagi.2024.1422350","volume":"16","author":"H Li","year":"2024","unstructured":"Li H, Cui X, Lin Y, Huang F, Tian A, Zhang R (2024) Gut microbiota changes in Alzheimer\u2019s disease spectrum: a systematic review and meta-analysis. Front Aging Neurosci 16:1422350. https:\/\/doi.org\/10.3389\/fnagi.2024.1422350","journal-title":"Front Aging Neurosci"},{"key":"6015_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1478557","volume":"16","author":"Q Chen","year":"2024","unstructured":"Chen Q et al (2024) Gut microbiota dysbiosis in patients with Alzheimer\u2019s disease and correlation with multiple cognitive domains. Front Aging Neurosci 16:1478557. https:\/\/doi.org\/10.3389\/fnagi.2024.1478557","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"6015_CR32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/cimb47090724","volume":"47","author":"A Borrego-Ruiz","year":"2025","unstructured":"Borrego-Ruiz A, Borrego JJ (2025) Microbial metabolomes in Alzheimer\u2019s disease: from pathogenesis to therapeutic potential. Curr Issues Mol Biol 47(9):724. https:\/\/doi.org\/10.3390\/cimb47090724","journal-title":"Curr Issues Mol Biol"},{"issue":"11","key":"6015_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278276","volume":"17","author":"JH Jung","year":"2022","unstructured":"Jung JH et al (2022) Gut microbiome alterations in preclinical Alzheimer\u2019s disease. PLoS ONE 17(11):e0278276. https:\/\/doi.org\/10.1371\/journal.pone.0278276","journal-title":"PLoS ONE"},{"issue":"1","key":"6015_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40035-024-00404-1","volume":"13","author":"YY Ma","year":"2024","unstructured":"Ma YY, Li X, Yu JT, Wang YJ (2024) Therapeutics for neurodegenerative diseases by targeting the gut microbiome. Transl Neurodegener 13(1):12. https:\/\/doi.org\/10.1186\/s40035-024-00404-1","journal-title":"Transl Neurodegener"},{"issue":"7","key":"6015_CR35","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3390\/jcm13071944","volume":"13","author":"GH Kim","year":"2024","unstructured":"Kim GH, Kim BR, Yoon HJ, Jeong JH (2024) Gut microbiota alterations correlate with amyloid burden in MCI due to Alzheimer\u2019s disease. J Clin Med 13(7):1944. https:\/\/doi.org\/10.3390\/jcm13071944","journal-title":"J Clin Med"},{"key":"6015_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106464","volume":"193","author":"K Yamashiro","year":"2024","unstructured":"Yamashiro K et al (2024) Gray matter free water links gut microbiota changes to Alzheimer\u2019s disease. Neurobiol Dis 193:106464. https:\/\/doi.org\/10.1016\/j.nbd.2024.106464","journal-title":"Neurobiol Dis"},{"issue":"1","key":"6015_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13195-025-01769-9","volume":"17","author":"KC Fan","year":"2025","unstructured":"Fan KC, Lin CC, Chiu YL, Koh SH, Liu YC, Chuang YF (2025) Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer\u2019s disease pathology. Alzheimers Res Ther 17(1):122. https:\/\/doi.org\/10.1186\/s13195-025-01769-9","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"6015_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/nu16030412","volume":"16","author":"DMS Dissanayaka","year":"2024","unstructured":"Dissanayaka DMS, Jayasena V, Rainey-Smith SR, Martins RN, Fernando WMADB (2024) Role of diet and gut microbiota in Alzheimer\u2019s disease. Nutrients 16(3):412. https:\/\/doi.org\/10.3390\/nu16030412","journal-title":"Nutrients"},{"key":"6015_CR39","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2023.0823-2","author":"L Qu","year":"2023","unstructured":"Qu L et al (2023) Microbiota\u2013gut\u2013brain axis dysregulation in Alzheimer\u2019s disease: multi-pathway effects and therapeutic potential. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2023.0823-2","journal-title":"Aging Dis"},{"issue":"18","key":"6015_CR40","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.3390\/jcm13185579","volume":"13","author":"MJ Luesma","year":"2024","unstructured":"Luesma MJ, L\u00f3pez-Marco L, Monz\u00f3n M, Santander S (2024) Enteric nervous system and its relationship with neurological diseases. J Clin Med 13(18):5579. https:\/\/doi.org\/10.3390\/jcm13185579","journal-title":"J Clin Med"},{"issue":"9","key":"6015_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10091838","volume":"10","author":"LM Dicks","year":"2022","unstructured":"Dicks LM (2022) Gut bacteria and neurotransmitters. Microorganisms 10(9):1838. https:\/\/doi.org\/10.3390\/microorganisms10091838","journal-title":"Microorganisms"},{"issue":"8","key":"6015_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2174\/1389200220666190725115503","volume":"20","author":"C Stasi","year":"2019","unstructured":"Stasi C, Sadalla S, Milani S (2019) The relationship between serotonin metabolism, gut microbiota and the gut\u2013brain axis. Curr Drug Metab 20(8):646\u2013655. https:\/\/doi.org\/10.2174\/1389200220666190725115503","journal-title":"Curr Drug Metab"},{"key":"6015_CR43","doi-asserted-by":"publisher","first-page":"1501134","DOI":"10.3389\/fnins.2024.1501134","volume":"18","author":"M Jiang","year":"2024","unstructured":"Jiang M et al (2024) Mechanisms of microbiota\u2013gut\u2013brain axis communication in anxiety disorders. Front Neurosci 18:1501134. https:\/\/doi.org\/10.3389\/fnins.2024.1501134","journal-title":"Front Neurosci"},{"key":"6015_CR44","doi-asserted-by":"publisher","first-page":"1554398","DOI":"10.3389\/fnagi.2025.1554398","volume":"17","author":"C He","year":"2025","unstructured":"He C, Chen B, Yang H, Zhou X (2025) The dual role of microglia in Alzheimer\u2019s disease: from immune regulation to pathological progression. Front Aging Neurosci 17:1554398. https:\/\/doi.org\/10.3389\/fnagi.2025.1554398","journal-title":"Front Aging Neurosci"},{"key":"6015_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y (2022) Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci 14:815347. https:\/\/doi.org\/10.3389\/fnagi.2022.815347","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"6015_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70091","volume":"30","author":"J Yang","year":"2024","unstructured":"Yang J et al (2024) The gut microbiota modulates neuroinflammation in Alzheimer\u2019s disease: crucial factors and mechanistic underpinnings. CNS Neurosci Ther 30(10):e70091. https:\/\/doi.org\/10.1111\/cns.70091","journal-title":"CNS Neurosci Ther"},{"issue":"18","key":"6015_CR47","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.3390\/ijms26188905","volume":"26","author":"HN Abdol Samat","year":"2025","unstructured":"Abdol Samat HN et al (2025) Inflammation\u2013microbiota interplay in Alzheimer\u2019s disease. Int J Mol Sci 26(18):8905. https:\/\/doi.org\/10.3390\/ijms26188905","journal-title":"Int J Mol Sci"},{"key":"6015_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000547746","volume":"32","author":"PZ Ling","year":"2025","unstructured":"Ling PZ, Wong KH, Ho YS, Cheng WY, Chang RC (2025) Gut\u2013brain axis modulation of sterile inflammation in Alzheimer\u2019s and Parkinson\u2019s disease. Neuroimmunomodulation 32:1\u201322. https:\/\/doi.org\/10.1159\/000547746","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"6015_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12974-025-03454-y","volume":"22","author":"Q Cao","year":"2025","unstructured":"Cao Q et al (2025) SCFA\u2013microglia signaling in the gut\u2013brain axis. J Neuroinflammation 22(1):133. https:\/\/doi.org\/10.1186\/s12974-025-03454-y","journal-title":"J Neuroinflammation"},{"issue":"32","key":"6015_CR50","doi-asserted-by":"publisher","first-page":"53829","DOI":"10.18632\/oncotarget.17754","volume":"8","author":"X Zhu","year":"2017","unstructured":"Zhu X et al (2017) Microbiota-gut-brain axis and the central nervous system. Oncotarget 8(32):53829\u201353838. https:\/\/doi.org\/10.18632\/oncotarget.17754","journal-title":"Oncotarget"},{"issue":"4","key":"6015_CR51","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF et al (2019) The microbiota-gut-brain axis. Physiol Rev 99(4):1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018","journal-title":"Physiol Rev"},{"issue":"7","key":"6015_CR52","doi-asserted-by":"publisher","first-page":"038","DOI":"10.1093\/gerona\/glaf038","volume":"80","author":"SK Prajapati","year":"2025","unstructured":"Prajapati SK, Jain S, Yadav H (2025) Age-related cognitive decline and dementia: interface of microbiome-immune-neuronal interactions. J Gerontol A Biol Sci Med Sci 80(7):038. https:\/\/doi.org\/10.1093\/gerona\/glaf038","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"6015_CR53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217(2):459\u2013472. https:\/\/doi.org\/10.1083\/jcb.201709069","journal-title":"J Cell Biol"},{"issue":"6","key":"6015_CR54","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/ijms27062603","volume":"27","author":"VM Mitrokhin","year":"2026","unstructured":"Mitrokhin VM, Kamkin AG, Babkina II, Savinkova IG, Shileiko SA, Ovchinnikov RS, Mladenov MI (2026) Heart-brain axis in viral myocarditis: shared cytokine pathways, blood-brain barrier crosstalk, and neuroinflammatory consequences. Int J Mol Sci 27(6):2603. https:\/\/doi.org\/10.3390\/ijms27062603","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6015_CR55","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12(6):719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheimers Dement"},{"key":"6015_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnagi.2018.00042","volume":"10","author":"X Zhan","year":"2018","unstructured":"Zhan X, Stamova B, Sharp FR (2018) Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer\u2019s disease brain. Front Aging Neurosci 10:42. https:\/\/doi.org\/10.3389\/fnagi.2018.00042","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"6015_CR57","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3233\/JAD-200306","volume":"78","author":"M Marizzoni","year":"2020","unstructured":"Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, Mombelli E, Mazzelli M, et al. (2020) Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer\u2019s disease. J Alzheimers Dis 78(2):683\u2013697. https:\/\/doi.org\/10.3233\/JAD-200306","journal-title":"J Alzheimers Dis"},{"issue":"7434","key":"6015_CR58","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493(7434):674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"issue":"4","key":"6015_CR59","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s10787-026-02180-y","volume":"34","author":"S Mandal","year":"2026","unstructured":"Mandal S, Aran KR (2026) Symbiotic in Alzheimer\u2019s disease: modulating the gut-brain axis for neuroimmune homeostasis and cognitive protection. Inflammopharmacology 34(4):2265\u20132283. https:\/\/doi.org\/10.1007\/s10787-026-02180-y","journal-title":"Inflammopharmacology"},{"issue":"7784","key":"6015_CR60","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669\u2013673. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"Nature"},{"key":"6015_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701282","volume":"12","author":"H Bai","year":"2021","unstructured":"Bai H, Zhang Q (2021) Activation of NLRP3 inflammasome and onset of Alzheimer\u2019s disease. Front Immunol 12:701282. https:\/\/doi.org\/10.3389\/fimmu.2021.701282","journal-title":"Front Immunol"},{"issue":"8","key":"6015_CR62","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro E et al (2015) Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med 21(8):880\u2013886. https:\/\/doi.org\/10.1038\/nm.3913","journal-title":"Nat Med"},{"issue":"3","key":"6015_CR63","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4103\/NRR.NRR-D-23-01508","volume":"20","author":"G Zhang","year":"2025","unstructured":"Zhang G et al (2025) Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: reflections on therapeutic strategies. Neural Regen Res 20(3):779\u2013793. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01508","journal-title":"Neural Regen Res"},{"issue":"7790","key":"6015_CR64","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D et al (2020) Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577(7790):399\u2013404. https:\/\/doi.org\/10.1038\/s41586-019-1895-7","journal-title":"Nature"},{"issue":"10","key":"6015_CR65","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W et al (2010) A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry 68(10):930\u2013941. https:\/\/doi.org\/10.1016\/j.biopsych.2010.06.012","journal-title":"Biol Psychiatry"},{"issue":"1","key":"6015_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11481-025-10210-9","volume":"20","author":"Ashvin","year":"2025","unstructured":"Ashvin et al (2025) Unraveling the immune puzzle: role of immunomodulation in Alzheimer\u2019s disease. J Neuroimmune Pharmacol 20(1):47. https:\/\/doi.org\/10.1007\/s11481-025-10210-9","journal-title":"J Neuroimmune Pharmacol"},{"issue":"8","key":"6015_CR67","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6015_CR68","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.2147\/JIR.S533106","volume":"18","author":"J Wang","year":"2025","unstructured":"Wang J, Ji D, Dai N, Qin C, Gong M, Fu B (2025) The modulation of neuroimmune responses in peripheral inflammation. J Inflamm Res 18:9015\u20139030. https:\/\/doi.org\/10.2147\/JIR.S533106","journal-title":"J Inflamm Res"},{"issue":"10","key":"6015_CR69","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33(10):1500\u20131513. https:\/\/doi.org\/10.1038\/jcbfm.2013.135","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"6015_CR70","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12035-025-05447-7","volume":"63","author":"SI Mohammad","year":"2025","unstructured":"Mohammad SI et al (2025) Mechanistic interplay of gut microbiota and blood-brain barrier integrity in neurodegenerative diseases. Mol Neurobiol 63(1):137. https:\/\/doi.org\/10.1007\/s12035-025-05447-7","journal-title":"Mol Neurobiol"},{"issue":"263","key":"6015_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V et al (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6(263):263ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3009759","journal-title":"Sci Transl Med"},{"issue":"6","key":"6015_CR72","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/ijms26062440","volume":"26","author":"AI Beltran-Velasco","year":"2025","unstructured":"Beltran-Velasco AI, Clemente-Su\u00e1rez VJ (2025) Impact of peripheral inflammation on blood-brain barrier dysfunction and its role in neurodegenerative diseases. Int J Mol Sci 26(6):2440. https:\/\/doi.org\/10.3390\/ijms26062440","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6015_CR73","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.medj.2021.03.018","volume":"2","author":"T Arora","year":"2021","unstructured":"Arora T, Vanslette AM, Hjorth SA, B\u00e4ckhed F (2021) Microbial regulation of enteroendocrine cells. Med 2(5):553\u2013570. https:\/\/doi.org\/10.1016\/j.medj.2021.03.018","journal-title":"Med"},{"issue":"1","key":"6015_CR74","doi-asserted-by":"publisher","first-page":"G53","DOI":"10.1152\/ajpgi.00346.2017","volume":"315","author":"CB Christiansen","year":"2018","unstructured":"Christiansen CB, Gabe MBN, Svendsen B, Dragsted LO, Rosenkilde MM, Holst JJ (2018) SCFA-induced GLP-1 and PYY secretion. Am J Physiol Gastrointest Liver Physiol 315(1):G53\u2013G65. https:\/\/doi.org\/10.1152\/ajpgi.00346.2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"21","key":"6015_CR75","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3390\/nu17213468","volume":"17","author":"NT Nguyen","year":"2025","unstructured":"Nguyen NT, Park JH (2025) Peptide YY in type 2 diabetes: a complementary gut hormone beyond GLP-1. Nutrients 17(21):3468. https:\/\/doi.org\/10.3390\/nu17213468","journal-title":"Nutrients"},{"issue":"1","key":"6015_CR76","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1038\/s41467-024-51076-4","volume":"15","author":"M Montaner","year":"2024","unstructured":"Montaner M et al (2024) A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion. Nat Commun 15(1):6941. https:\/\/doi.org\/10.1038\/s41467-024-51076-4","journal-title":"Nat Commun"},{"issue":"11","key":"6015_CR77","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/metabo13111166","volume":"13","author":"Y Hou","year":"2023","unstructured":"Hou Y, Li J, Ying S (2023) Tryptophan metabolism and gut microbiota: a regulatory axis integrating immunity and cancer. Metabolites 13(11):1166. https:\/\/doi.org\/10.3390\/metabo13111166","journal-title":"Metabolites"},{"issue":"1","key":"6015_CR78","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-025-03434-2","volume":"22","author":"B Bharathwaj Chetty","year":"2025","unstructured":"Bharathwaj Chetty B et al (2025) Gut microbiota influence in brain cancer milieu. J Neuroinflammation 22(1):129. https:\/\/doi.org\/10.1186\/s12974-025-03434-2","journal-title":"J Neuroinflammation"},{"issue":"2","key":"6015_CR79","doi-asserted-by":"publisher","first-page":"240","DOI":"10.17305\/bb.2025.12921","volume":"26","author":"X Ji","year":"2025","unstructured":"Ji X, Wang J, Lan T, Zhao D, Xu P (2025) Gut microbial metabolites and the brain\u2013gut axis in Alzheimer\u2019s disease: a review. Biomolecules Biomed 26(2):240\u2013250. https:\/\/doi.org\/10.17305\/bb.2025.12921","journal-title":"Biomolecules Biomed"},{"key":"6015_CR80","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3389\/fimmu.2019.00285","volume":"10","author":"F G\u00f3mez-Ch\u00e1vez","year":"2019","unstructured":"G\u00f3mez-Ch\u00e1vez F et al (2019) Maternal immune response and vertical transmission in toxoplasmosis. Front Immunol 10:285. https:\/\/doi.org\/10.3389\/fimmu.2019.00285","journal-title":"Front Immunol"},{"issue":"8","key":"6015_CR81","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/nu11081806","volume":"11","author":"E Dimidi","year":"2019","unstructured":"Dimidi E, Cox SR, Rossi M, Whelan K (2019) Fermented foods and gut microbiota interactions. Nutrients 11(8):1806. https:\/\/doi.org\/10.3390\/nu11081806","journal-title":"Nutrients"},{"key":"6015_CR82","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fnins.2020.00259","volume":"14","author":"D Pan","year":"2020","unstructured":"Pan D, Zeng A, Jia L, Huang Y, Frizzell T, Song X (2020) Early detection of Alzheimer\u2019s disease using MRI and CNN ensemble learning. Front Neurosci 14:259. https:\/\/doi.org\/10.3389\/fnins.2020.00259","journal-title":"Front Neurosci"},{"key":"6015_CR83","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuroscience.2022.11.001","volume":"507","author":"S Anand","year":"2022","unstructured":"Anand S, Ansari MA, Sukrutha SK, Alomary MN, Khan AA, Elderdery AY (2022) Resolvins lipid mediators: potential therapeutic targets in Alzheimer and Parkinson disease. Neuroscience 507:139\u2013148. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.11.001","journal-title":"Neuroscience"},{"key":"6015_CR84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2045-8118-11-14","volume":"11","author":"R G\u00fcnther","year":"2014","unstructured":"G\u00fcnther R, Krause E, Sch\u00fcmann M (2014) Removal of albumin and immunoglobulins from canine CSF. Fluids Barriers CNS 11:14. https:\/\/doi.org\/10.1186\/2045-8118-11-14","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"6015_CR85","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s43440-025-00796-5","volume":"77","author":"A Strz\u0119pa","year":"2025","unstructured":"Strz\u0119pa A, Szczepanik M (2025) Microbiota modulation in Alzheimer\u2019s disease prevention. Pharmacol Rep 77(6):1468\u20131490. https:\/\/doi.org\/10.1007\/s43440-025-00796-5","journal-title":"Pharmacol Rep"},{"issue":"1","key":"6015_CR86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-024-00720-0","volume":"19","author":"YX Luo","year":"2024","unstructured":"Luo YX, Yang LL, Yao XQ (2024) Gut microbiota\u2013lipid crosstalk in Alzheimer\u2019s disease. Mol Neurodegener 19(1):35. https:\/\/doi.org\/10.1186\/s13024-024-00720-0","journal-title":"Mol Neurodegener"},{"issue":"10","key":"6015_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70250","volume":"169","author":"K Ganggang","year":"2025","unstructured":"Ganggang K et al (2025) From molecular docking to rat models: butyrate from a high-fiber diet inhibits HDAC1 and NLRP3 inflammasome to alleviate oxidative stress and inflammation after spinal cord injury. J Neurochem 169(10):e70250. https:\/\/doi.org\/10.1111\/jnc.70250","journal-title":"J Neurochem"},{"issue":"11","key":"6015_CR88","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/cns.14252","volume":"29","author":"C Gao","year":"2023","unstructured":"Gao C et al (2023) Early changes of fecal short-chain fatty acid levels in patients with mild cognitive impairments. CNS Neurosci Ther 29(11):3657\u20133666. https:\/\/doi.org\/10.1111\/cns.14252","journal-title":"CNS Neurosci Ther"},{"key":"6015_CR89","doi-asserted-by":"publisher","first-page":"1535356","DOI":"10.3389\/fmicb.2025.1535356","volume":"16","author":"J Zhu","year":"2025","unstructured":"Zhu J et al (2025) Gut microbiota influence on the gut\u2013brain\u2013kidney axis and chronic kidney disease. Front Microbiol 16:1535356. https:\/\/doi.org\/10.3389\/fmicb.2025.1535356","journal-title":"Front Microbiol"},{"issue":"5","key":"6015_CR90","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.14336\/AD.2024.0134","volume":"15","author":"L Xie","year":"2024","unstructured":"Xie L et al (2024) Tryptophan metabolism in Alzheimer\u2019s disease with the involvement of microglia and astrocyte crosstalk and gut-brain axis. Aging Dis 15(5):2168\u20132190. https:\/\/doi.org\/10.14336\/AD.2024.0134","journal-title":"Aging Dis"},{"issue":"1","key":"6015_CR91","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS et al (2024) Microbiota\u2013gut\u2013brain axis therapeutics in neurodegeneration. Signal Transduct Target Ther 9(1):37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","journal-title":"Signal Transduct Target Ther"},{"key":"6015_CR92","doi-asserted-by":"publisher","first-page":"1617690","DOI":"10.3389\/fnagi.2025.1617690","volume":"17","author":"G Li","year":"2025","unstructured":"Li G, Li S, Zhou W (2025) Kynurenine pathway in exercise-mediated prevention of Alzheimer\u2019s disease. Front Aging Neurosci 17:1617690. https:\/\/doi.org\/10.3389\/fnagi.2025.1617690","journal-title":"Front Aging Neurosci"},{"key":"6015_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2025.11.004","volume":"215","author":"DM Asante","year":"2025","unstructured":"Asante DM, Vyavahare S, Shukla M, McGee-Lawrence ME, Isales CM, Fulzele S (2025) Exercise-driven changes in tryptophan metabolism and healthy aging. Biochimie 215:1\u201310. https:\/\/doi.org\/10.1016\/j.biochi.2025.11.004","journal-title":"Biochimie"},{"issue":"17","key":"6015_CR94","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.3390\/molecules30173628","volume":"30","author":"M Owe-Larsson","year":"2025","unstructured":"Owe-Larsson M, Drobek D, Iwaniak P, Kloc R, Urbanska EM, Chwil M (2025) Microbiota-derived tryptophan metabolite indole-3-propionic acid-emerging role in neuroprotection. Molecules 30(17):3628. https:\/\/doi.org\/10.3390\/molecules30173628","journal-title":"Molecules"},{"issue":"12","key":"6015_CR95","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1093\/gerona\/glad226","volume":"78","author":"SK Prajapati","year":"2023","unstructured":"Prajapati SK et al (2023) The triple alliance: microbiome, mitochondria, and metabolites in the context of age-related cognitive decline and Alzheimer\u2019s disease. J Gerontol A Biol Sci Med Sci 78(12):2187\u20132202. https:\/\/doi.org\/10.1093\/gerona\/glad226","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"6015_CR96","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.7150\/ijbs.115359","volume":"21","author":"H Miao","year":"2025","unstructured":"Miao H, Zhang SJ, Wu X, Li P, Zhao YY (2025) Tryptophan metabolism as a target in gut microbiota, ageing and kidney disease. Int J Biol Sci 21(10):4374\u20134387. https:\/\/doi.org\/10.7150\/ijbs.115359","journal-title":"Int J Biol Sci"},{"key":"6015_CR97","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fnins.2019.01365","volume":"13","author":"H Kaur","year":"2019","unstructured":"Kaur H, Bose C, Mande SS (2019) Tryptophan metabolism by gut microbiome and gut\u2013brain axis. Front Neurosci 13:1365. https:\/\/doi.org\/10.3389\/fnins.2019.01365","journal-title":"Front Neurosci"},{"issue":"2","key":"6015_CR98","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JAD-210608","volume":"84","author":"A Mulak","year":"2021","unstructured":"Mulak A (2021) Bile acids as modulators of the brain\u2013gut\u2013microbiota axis in Alzheimer\u2019s disease. J Alzheimers Dis 84(2):461\u2013477. https:\/\/doi.org\/10.3233\/JAD-210608","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"6015_CR99","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40520-024-02729-3","volume":"36","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Valizadeh P, Fallahi MS (2024) Alzheimer\u2019s disease neuroimaging initiative bile acid profiles associated with CSF and PET biomarkers in Alzheimer\u2019s disease. Aging Clin Exp Res 36(1):62. https:\/\/doi.org\/10.1007\/s40520-024-02729-3","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"6015_CR100","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","volume":"15","author":"S Mahmoudian Dehkordi","year":"2019","unstructured":"Mahmoudian Dehkordi S, Arnold M, Nho K (2019) Altered bile acid profiles and cognitive impairment in Alzheimer\u2019s disease. Alzheimers Dement 15(1):76\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.217","journal-title":"Alzheimers Dement"},{"issue":"2","key":"6015_CR101","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/clinem\/dgac659","volume":"108","author":"L Qi","year":"2023","unstructured":"Qi L, Chen Y (2023) Circulating bile acids as biomarkers for disease diagnosis. J Clin Endocrinol Metab 108(2):251\u2013270. https:\/\/doi.org\/10.1210\/clinem\/dgac659","journal-title":"J Clin Endocrinol Metab"},{"key":"6015_CR102","doi-asserted-by":"publisher","first-page":"1582119","DOI":"10.3389\/fimmu.2025.1582119","volume":"16","author":"W Lei","year":"2025","unstructured":"Lei W et al (2025) Gut microbiota-driven neuroinflammation in Alzheimer\u2019s disease: mechanisms and therapeutic opportunities. Front Immunol 16:1582119. https:\/\/doi.org\/10.3389\/fimmu.2025.1582119","journal-title":"Front Immunol"},{"key":"6015_CR103","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fnins.2018.00896","volume":"12","author":"WJ Lukiw","year":"2018","unstructured":"Lukiw WJ, Cong L, Jaber V, Zhao Y (2018) Microbiome-derived lipopolysaccharide selectively inhibits neurofilament light chain gene expression. Front Neurosci 12:896. https:\/\/doi.org\/10.3389\/fnins.2018.00896","journal-title":"Front Neurosci"},{"key":"6015_CR104","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcimb.2020.00022","volume":"10","author":"WJ Lukiw","year":"2020","unstructured":"Lukiw WJ (2020) Gastrointestinal tract microbiome-derived neurotoxins as potent neuroinflammatory signals. Front Cell Infect Microbiol 10:22. https:\/\/doi.org\/10.3389\/fcimb.2020.00022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"6015_CR105","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","volume":"56","author":"DO Seo","year":"2024","unstructured":"Seo DO, Holtzman DM (2024) Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med 56(1):86\u201394. https:\/\/doi.org\/10.1038\/s12276-023-01146-2","journal-title":"Exp Mol Med"},{"issue":"1","key":"6015_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41538-025-00599-1","volume":"9","author":"Y Wang","year":"2025","unstructured":"Wang Y et al (2025) Dietary choline-derived Trimethylamine N-oxide impairs hippocampal neuronal function via PANoptosis activation. npj Sci Food 9(1):235. https:\/\/doi.org\/10.1038\/s41538-025-00599-1","journal-title":"npj Sci Food"},{"issue":"4","key":"6015_CR107","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/microorganisms3040641","volume":"3","author":"A Baars","year":"2015","unstructured":"Baars A, Oosting A, Knol J, Garssen J, van Bergenhenegouwen J (2015) Gut microbiota as a therapeutic target via FXR and TGR5. Microorganisms 3(4):641\u2013666. https:\/\/doi.org\/10.3390\/microorganisms3040641","journal-title":"Microorganisms"},{"issue":"3","key":"6015_CR108","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/ijms26031373","volume":"26","author":"H Xie","year":"2025","unstructured":"Xie H et al (2025) The role of gut microbiota-derived trimethylamine N-oxide in the pathogenesis and treatment of mild cognitive impairment. Int J Mol Sci 26(3):1373. https:\/\/doi.org\/10.3390\/ijms26031373","journal-title":"Int J Mol Sci"},{"issue":"19","key":"6015_CR109","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1080\/10408398.2023.2176464","volume":"64","author":"C Wang","year":"2024","unstructured":"Wang C et al (2024) Gut microbiome-based strategies for host health and disease. Crit Rev Food Sci Nutr 64(19):6834\u20136849. https:\/\/doi.org\/10.1080\/10408398.2023.2176464","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"6","key":"6015_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00470","volume":"21","author":"JW Kang","year":"2024","unstructured":"Kang JW, Vemuganti V, Kuehn JF, Ulland TK, Rey FE, Bendlin BB (2024) Gut microbial metabolism in Alzheimer\u2019s disease. Neurotherapeutics 21(6):e00470. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00470","journal-title":"Neurotherapeutics"},{"key":"6015_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105403","volume":"156","author":"MA Pappolla","year":"2021","unstructured":"Pappolla MA, Perry G, Fang X, Zagorski M, Sambamurti K, Poeggeler B (2021) Indoles as mediators of the gut\u2013brain axis in Alzheimer\u2019s disease. Neurobiol Dis 156:105403. https:\/\/doi.org\/10.1016\/j.nbd.2021.105403","journal-title":"Neurobiol Dis"},{"key":"6015_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117228","volume":"178","author":"M Wu","year":"2024","unstructured":"Wu M et al (2024) Molecular mechanisms and therapeutic strategies of bile acids in Alzheimer\u2019s disease from a microbiota\u2013gut\u2013brain axis perspective. Biomed Pharmacother 178:117228. https:\/\/doi.org\/10.1016\/j.biopha.2024.117228","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"6015_CR113","doi-asserted-by":"publisher","first-page":"2271613","DOI":"10.1080\/19490976.2023.2271613","volume":"15","author":"T Zhang","year":"2023","unstructured":"Zhang T, Gao G, Kwok LY, Sun Z (2023) Gut microbiome-targeted therapies for Alzheimer\u2019s disease. Gut Microbes 15(2):2271613. https:\/\/doi.org\/10.1080\/19490976.2023.2271613","journal-title":"Gut Microbes"},{"key":"6015_CR114","doi-asserted-by":"publisher","first-page":"1465455","DOI":"10.3389\/fmicb.2024.1465455","volume":"15","author":"Y Yu","year":"2024","unstructured":"Yu Y, Yin Y, Deng J, Yang X, Bai S, Yu R (2024) Causal effects of gut microbiome on trimethylamine N-oxide: Mendelian randomization evidence. Front Microbiol 15:1465455. https:\/\/doi.org\/10.3389\/fmicb.2024.1465455","journal-title":"Front Microbiol"},{"key":"6015_CR115","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40495-024-00364-0","volume":"10","author":"N Kumari","year":"2024","unstructured":"Kumari N et al (2024) Recent insights on the prospective role of phytocompounds in modulating gut\u2013brain axis. Curr Pharmacol Rep 10:330\u2013348. https:\/\/doi.org\/10.1007\/s40495-024-00364-0","journal-title":"Curr Pharmacol Rep"},{"issue":"1","key":"6015_CR116","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-023-00595-7","volume":"18","author":"S Chandra","year":"2023","unstructured":"Chandra S, Sisodia SS, Vassar R (2023) The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored. Mol Neurodegener 18(1):9. https:\/\/doi.org\/10.1186\/s13024-023-00595-7","journal-title":"Mol Neurodegener"},{"issue":"14","key":"6015_CR117","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3390\/foods13142301","volume":"13","author":"J Lee","year":"2024","unstructured":"Lee J et al (2024) In vitro evaluation of probiotic Lactobacillus and Bifidobacterium strains. Foods 13(14):2301. https:\/\/doi.org\/10.3390\/foods13142301","journal-title":"Foods"},{"key":"6015_CR118","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbr.2015.02.044","volume":"287","author":"HM Savignac","year":"2015","unstructured":"Savignac HM, Tramullas M, Kiely B, Dinan TG, Cryan JF (2015) Bifidobacteria modulate cognition in an anxious mouse strain. Behav Brain Res 287:59\u201372. https:\/\/doi.org\/10.1016\/j.bbr.2015.02.044","journal-title":"Behav Brain Res"},{"issue":"12","key":"6015_CR119","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/nu14122543","volume":"14","author":"M Abdelhamid","year":"2022","unstructured":"Abdelhamid M, Zhou C, Jung CG, Michikawa M (2022) Probiotic Bifidobacterium breve mitigates Alzheimer\u2019s pathology. Nutrients 14(12):2543. https:\/\/doi.org\/10.3390\/nu14122543","journal-title":"Nutrients"},{"issue":"8","key":"6015_CR120","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00178-25","volume":"13","author":"Y Shiqing","year":"2025","unstructured":"Shiqing Y et al (2025) Clostridium butyricum enhances cognition in APP\/PS1 mice. Microbiol Spectr 13(8):e0017825. https:\/\/doi.org\/10.1128\/spectrum.00178-25","journal-title":"Microbiol Spectr"},{"issue":"1","key":"6015_CR121","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/nu16010016","volume":"16","author":"YC Hsu","year":"2024","unstructured":"Hsu YC et al (2024) Efficacy of probiotic supplements on BDNF, inflammatory biomarkers, oxidative stress and cognitive function in Alzheimer\u2019s dementia: a randomized controlled study. Nutrients 16(1):16. https:\/\/doi.org\/10.3390\/nu16010016","journal-title":"Nutrients"},{"issue":"11","key":"6015_CR122","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/microorganisms9112310","volume":"9","author":"JW Kang","year":"2021","unstructured":"Kang JW, Zivkovic AM (2021) Utility of prebiotics in modulating Alzheimer\u2019s disease. Microorganisms 9(11):2310. https:\/\/doi.org\/10.3390\/microorganisms9112310","journal-title":"Microorganisms"},{"key":"6015_CR123","doi-asserted-by":"publisher","first-page":"1169624","DOI":"10.3389\/fendo.2023.1169624","volume":"14","author":"KE Masse","year":"2023","unstructured":"Masse KE, Lu VB (2023) Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease. Front Endocrinol 14:1169624. https:\/\/doi.org\/10.3389\/fendo.2023.1169624","journal-title":"Front Endocrinol"},{"issue":"2","key":"6015_CR124","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/ijms24021001","volume":"24","author":"JT Matheson","year":"2023","unstructured":"Matheson JT, Holsinger RMD (2023) Role of fecal microbiota transplantation in neurodegenerative diseases. Int J Mol Sci 24(2):1001. https:\/\/doi.org\/10.3390\/ijms24021001","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6015_CR125","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41398-019-0525-3","volume":"9","author":"J Sun","year":"2019","unstructured":"Sun J et al (2019) Fecal microbiota transplantation alleviates Alzheimer-like pathology in APP\/PS1 mice. Transl Psychiatry 9(1):189. https:\/\/doi.org\/10.1038\/s41398-019-0525-3","journal-title":"Transl Psychiatry"},{"issue":"11","key":"6015_CR126","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1080\/09168451.2019.1644149","volume":"83","author":"Y Fujii","year":"2019","unstructured":"Fujii Y et al (2019) Fecal metabolite profiles after transplantation of Alzheimer\u2019s disease microbiota. Biosci Biotechnol Biochem 83(11):2144\u20132152. https:\/\/doi.org\/10.1080\/09168451.2019.1644149","journal-title":"Biosci Biotechnol Biochem"},{"key":"6015_CR127","doi-asserted-by":"publisher","first-page":"1118529","DOI":"10.3389\/fmicb.2023.1118529","volume":"14","author":"K Kasarello","year":"2023","unstructured":"Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K (2023) Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol 14:1118529. https:\/\/doi.org\/10.3389\/fmicb.2023.1118529","journal-title":"Front Microbiol"},{"key":"6015_CR128","doi-asserted-by":"publisher","first-page":"1559521","DOI":"10.3389\/fmicb.2025.1559521","volume":"16","author":"A Safarchi","year":"2025","unstructured":"Safarchi A, Al-Qadami G, Tran CD, Conlon M (2025) Dysbiosis and resilience in the human gut microbiome. Front Microbiol 16:1559521. https:\/\/doi.org\/10.3389\/fmicb.2025.1559521","journal-title":"Front Microbiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06015-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06015-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06015-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:38:21Z","timestamp":1781872701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06015-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6015"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06015-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"706"}}